May 2015

Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome

Conditions:   Aplastic Anemia;   Hypoplastic Myelodysplastic Syndrome
Interventions:   Drug: BL-8040;   Drug: horse anti-thymocyte globulin (hATG);   Drug: Methylprednisolone;   Drug: Cyclosporine
Sponsor:   BioLineRx, Ltd.
Recruiting - verified June 2016

Clinical Trial of Ezogabine (Retigabine) in ALS Subjects

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: Ezogabine;   Drug: Placebo
Sponsors:   Brian Wainger;   ALS Association;   GlaxoSmithKline;   Harvard University;   Massachusetts General Hospital
Recruiting - verified December 2016

Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Device: Faros Sensor (FS) and LifeInsight Hub;   Device: Fast Fix electrode patch;   Procedure: Quantitative Measure of Speech (Core Phase Only)
Sponsors:   GlaxoSmithKline;   McLaren Applied Technologies
Active, not recruiting - verified July 2016

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

Condition:   Leukemia
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Drug: Clofarabine;   Radiation: Total Body Irradiation (TBI);   Drug: Thymoglobulin;   Biological: Stem Cell Infusion;   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Decitabine;   Drug: Cytarabine;   Drug: Idarubicin
Sponsor:   M.D. Anderson Cancer Center
Recruiting - verified September 2016